Skip to content

Evaluation of a Unani Formulation in the Management of Knee Osteoarthritis A Randomized Single-Blind Controlled Clinical Study

Therapeutic evaluation of a Unani formulation in the treatment of Waja al Mafasil/Waja ur Rukba (Knee Osteoarthritis) a randomized single blind standard controlled clinical trial - Nill

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/01/101374
Enrollment
38
Registered
2026-01-16
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M179- Osteoarthritis of knee, unspecified

Interventions

Intervention1: Unani formulation Dimad: Test drug Unani formulation Dimad made up of Roghan e Baboona Moam Ard e Baqla Mode of administration Local application Dosage Twice daily Follow up on 7th 14th

Sponsors

Luqman Unani Medical College Hospital and Research Centre
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients of both male and female gender aged 30 to 65 years with clinically diagnosed knee osteoarthritis and Kellgren Lawrence grading scale 0 to 3 were included in the study

Exclusion criteria

Exclusion criteria: Patients with systemic illness endocrine or metabolic diseases septic arthritis pregnancy or lactation History of knee joint surgery tidal lavage or arthroscopy within the past 12 months History of alcohol or drug abuse Psychological or psychiatric illness Ongoing steroid therapy Immunosuppressive diseases or drug use and those who were non compliant with the trial protocol were excluded from the study

Design outcomes

Primary

MeasureTime frame
Visual Analogue Scale (VAS) Knee injury and Osteoarthritis Outcome Score (KOOS) Kellgren Lawrence(KL) grading scaleTimepoint: KOOS and KL grading scale Assess Baseline and 28th day VAS scale Assess Baseline 7th 14th 21st and 28th day

Secondary

MeasureTime frame
Change in Active range of motion (AROM) Change in Passive range of motion (PROM) Timepoint: Baseline 7th 14th 21st & 28th day

Countries

India

Contacts

Public ContactDr Shaikh Nisar Ahmed Abbas

Luqman Unani Medical College Hospital and Research Centre Vijayapura

dr.sabamamdapur@gmail.com09611497816

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026